Evidence map›Paper›PMID 34271028›Full record

ArticleProgress in biophysics and molecular biology2021

The cancer puzzle: Welcome to organicism.

Ana M Soto, Carlos Sonnenschein

Abstract read
In one paragraph

Article in Progress in biophysics and molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ana M SotoTufts University School of Medicine, Boston, Massachusetts, USA; Centre Cavaillès, République des Savoirs, École Normale Supérieure, Paris, France. Electronic address: ana.soto@tufts.edu.
Carlos SonnenscheinTufts University School of Medicine, Boston, Massachusetts, USA; Centre Cavaillès, République des Savoirs, École Normale Supérieure, Paris, France. Electronic address: carlos.sonnenschein@tufts.edu.

Funding

BPA effects on the gut microbiomeR21ES026283 · NIEHS · TUFTS UNIVERSITY BOSTON · PI RUBIN, BEVERLY S, SOTO, ANA · 2016 to 2017
$454k
Development in a dish: an ex-vivo fetal mammary assay for toxicological researchUH2ES030045 · NIEHS · TUFTS UNIVERSITY BOSTON · PI SOTO, ANA · 2019 to 2020
$454k
NIEHS NIH HHS R21 ES026283NIEHS NIH HHS UH2 ES030045
6 · The paper itself

Abstract

During the fifty years since President Nixon declared the "War on Cancer", those inside and outside the cancer community have witnessed the systematic moving of the goalposts attitude to accommodate evidence into an inadequate theory, that is, the Somatic Mutation Theory (SMT). This sorry state promoted a renewable yearly promise that at the end of the next 10-year period the promises uttered in 1971 would become reality. Each failure triggered calls to do more of the same research under the same theory, routinely using more and more sophisticated technology. Meanwhile, in the last few years, an unambiguous general consensus has emerged acknowledging that this overall long, intensive effort has failed, and that it is likely that the solution to the cancer problem resides elsewhere, namely, in alternative theoretical principles of biology. In this essay we concentrate, first, on the big picture, from the philosophical stance (reductionism versus organicism) to the need to adopt rigorous theories. From this novel perspective we conceptualize cancer as a disease of tissue organization akin to development gone awry. Finally, having identified both a promising stance and a useful theory, i.e., the tissue organization field theory (TOFT), we call for abandoning the SMT and for adopting the more promising TOFT.

Indexed as

CarcinogenesisNeoplasmsHumansCancerOrganicismReductionismSomatic mutation theoryTissue organization field theory

Identifiers

PMID34271028
PMCPMC8571715

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.